Matches in SemOpenAlex for { <https://semopenalex.org/work/W2802507673> ?p ?o ?g. }
- W2802507673 endingPage "596" @default.
- W2802507673 startingPage "589" @default.
- W2802507673 abstract "The chronic inflammation associated with rheumatoid arthritis (RA) leads to focal and systemic bone erosion of the joints resulting in a crippling disability. Recent reports indicate an increase in the incidence of RA in the coming years, placing a significant burden on healthcare resources. The incidence of RA is observed to be increasing with age and a significant proportion of those new cases will be aggressively erosive.The altered physiology, due to immune disturbances, contributes towards RA pathogenesis. The imbalance of inflammatory cytokines and non-cytokine immune modulators such as prostaglandin E2 (PGE2) and IL-23-induced pathogenic IL-17, plays a crucial role in persistent inflammation and bone degradation during RA. However, the molecular mechanism of IL-23, a key cytokine, and PGE2 in the development and perpetuation of IL-17 producing effector Th17 cells is poorly understood.This review focuses on research findings that provide insight into the contribution of PGE2 and IL-23 during the development of pathogenic Th17 cells. We also highlight the key transcriptional factors required for Th17 development and therapeutic strategies to disrupt the interaction between IL-23 and IL-17 to prevent the end-organ damage in RA." @default.
- W2802507673 created "2018-05-17" @default.
- W2802507673 creator A5006385771 @default.
- W2802507673 creator A5010626357 @default.
- W2802507673 creator A5013933345 @default.
- W2802507673 creator A5048296187 @default.
- W2802507673 creator A5049183914 @default.
- W2802507673 creator A5051551064 @default.
- W2802507673 creator A5055989095 @default.
- W2802507673 creator A5061311984 @default.
- W2802507673 creator A5064207201 @default.
- W2802507673 date "2018-04-30" @default.
- W2802507673 modified "2023-09-26" @default.
- W2802507673 title "Prostaglandin E2 and IL-23 interconnects STAT3 and RoRγ pathways to initiate Th17 CD4+ T-cell development during rheumatoid arthritis" @default.
- W2802507673 cites W1534835417 @default.
- W2802507673 cites W1590451869 @default.
- W2802507673 cites W1601290042 @default.
- W2802507673 cites W1607828984 @default.
- W2802507673 cites W1697354033 @default.
- W2802507673 cites W1847326477 @default.
- W2802507673 cites W1856119395 @default.
- W2802507673 cites W1873874031 @default.
- W2802507673 cites W1906201952 @default.
- W2802507673 cites W1940681873 @default.
- W2802507673 cites W1966062801 @default.
- W2802507673 cites W1967937911 @default.
- W2802507673 cites W1988233881 @default.
- W2802507673 cites W2004805241 @default.
- W2802507673 cites W2006249161 @default.
- W2802507673 cites W2008713912 @default.
- W2802507673 cites W2012770902 @default.
- W2802507673 cites W2015347941 @default.
- W2802507673 cites W2018645348 @default.
- W2802507673 cites W2033981053 @default.
- W2802507673 cites W2034516005 @default.
- W2802507673 cites W2036816001 @default.
- W2802507673 cites W2047677831 @default.
- W2802507673 cites W2062394418 @default.
- W2802507673 cites W2064645845 @default.
- W2802507673 cites W2073614445 @default.
- W2802507673 cites W2073791328 @default.
- W2802507673 cites W2074129224 @default.
- W2802507673 cites W2086264253 @default.
- W2802507673 cites W2088104136 @default.
- W2802507673 cites W2092304883 @default.
- W2802507673 cites W2092602103 @default.
- W2802507673 cites W2093949724 @default.
- W2802507673 cites W2097404490 @default.
- W2802507673 cites W2100564391 @default.
- W2802507673 cites W2101365364 @default.
- W2802507673 cites W2104040734 @default.
- W2802507673 cites W2107235439 @default.
- W2802507673 cites W2109955020 @default.
- W2802507673 cites W2110826367 @default.
- W2802507673 cites W2112866067 @default.
- W2802507673 cites W2114982159 @default.
- W2802507673 cites W2123166427 @default.
- W2802507673 cites W2123580807 @default.
- W2802507673 cites W2124060758 @default.
- W2802507673 cites W2126894693 @default.
- W2802507673 cites W2131410859 @default.
- W2802507673 cites W2132822330 @default.
- W2802507673 cites W2137717947 @default.
- W2802507673 cites W2142017607 @default.
- W2802507673 cites W2147843944 @default.
- W2802507673 cites W2153434457 @default.
- W2802507673 cites W2155013311 @default.
- W2802507673 cites W2155779547 @default.
- W2802507673 cites W2157630878 @default.
- W2802507673 cites W2169031577 @default.
- W2802507673 cites W2170758122 @default.
- W2802507673 cites W2203736446 @default.
- W2802507673 cites W2550072129 @default.
- W2802507673 cites W2772222670 @default.
- W2802507673 cites W2917800966 @default.
- W2802507673 cites W4211054359 @default.
- W2802507673 doi "https://doi.org/10.1007/s00011-018-1153-8" @default.
- W2802507673 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6071319" @default.
- W2802507673 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29713730" @default.
- W2802507673 hasPublicationYear "2018" @default.
- W2802507673 type Work @default.
- W2802507673 sameAs 2802507673 @default.
- W2802507673 citedByCount "28" @default.
- W2802507673 countsByYear W28025076732018 @default.
- W2802507673 countsByYear W28025076732019 @default.
- W2802507673 countsByYear W28025076732020 @default.
- W2802507673 countsByYear W28025076732021 @default.
- W2802507673 countsByYear W28025076732022 @default.
- W2802507673 countsByYear W28025076732023 @default.
- W2802507673 crossrefType "journal-article" @default.
- W2802507673 hasAuthorship W2802507673A5006385771 @default.
- W2802507673 hasAuthorship W2802507673A5010626357 @default.
- W2802507673 hasAuthorship W2802507673A5013933345 @default.
- W2802507673 hasAuthorship W2802507673A5048296187 @default.
- W2802507673 hasAuthorship W2802507673A5049183914 @default.
- W2802507673 hasAuthorship W2802507673A5051551064 @default.
- W2802507673 hasAuthorship W2802507673A5055989095 @default.
- W2802507673 hasAuthorship W2802507673A5061311984 @default.